Literature DB >> 10867126

Eicosanoids and the large intestine.

W Krause1, R N DuBois.   

Abstract

During the past three decades, many studies have been conducted to determine the precise role of eicosanoids in colorectal physiology and pathophysiology. This research has increased our understanding of bioactive lipid signaling, and may contribute to the development of more effective therapeutic modalities for digestive diseases in the future. The purpose of this report is to provide a brief overview of the role of eicosanoids in the colon and rectum. This information has been organized according to both functional and disease-related categories. The role of eicosanoids in colonic secretion, motility, inflammatory bowel disease, and colorectal neoplasia will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867126     DOI: 10.1016/s0090-6980(00)00069-1

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  11 in total

1.  Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2.

Authors:  Xuan-Zheng Shi; You-Min Lin; Don W Powell; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-04       Impact factor: 4.052

2.  Prophylactic and therapeutic benefits of COX-2 inhibitor on motility dysfunction in bowel obstruction: roles of PGE₂ and EP receptors.

Authors:  You-Min Lin; Sushil K Sarna; Xuan-Zheng Shi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

3.  The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.

Authors:  Kenji Kabashima; Tomomi Saji; Takahiko Murata; Miyako Nagamachi; Toshiyuki Matsuoka; Eri Segi; Kazuhito Tsuboi; Yukihiko Sugimoto; Takuya Kobayashi; Yoshiki Miyachi; Atsushi Ichikawa; Shuh Narumiya
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

4.  Synergistic regulation of COX-2 expression by bombesin and transforming growth factor-beta.

Authors:  Yan-Shi Guo; Zihong Chen; Xiao-Dong Wen; Tien C Ko; Courtney M Townsend; Mark R Hellmich
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

5.  Prostaglandin E2 and Krüppel-like transcription factors synergistically induce the expression of decay-accelerating factor in intestinal epithelial cells.

Authors:  Jinyi Shao; Vincent W Yang; Hongmiao Sheng
Journal:  Immunology       Date:  2008-04-16       Impact factor: 7.397

Review 6.  Arachidonic acid and colorectal carcinogenesis.

Authors:  Raymond Jones; Luis-Alfonso Adel-Alvarez; Osvaldo Rascon Alvarez; Russell Broaddus; Siddhartha Das
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  Loss of EP2 receptor subtype in colonic cells compromise epithelial barrier integrity by altering claudin-4.

Authors:  Manigandan Lejeune; France Moreau; Kris Chadee
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 8.  Mechanical Regulation of Gene Expression in Gut Smooth Muscle Cells.

Authors:  Xuan-Zheng Shi
Journal:  Front Physiol       Date:  2017-12-05       Impact factor: 4.566

Review 9.  Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders.

Authors:  Ramasatyaveni Geesala; You-Min Lin; Ke Zhang; Xuan-Zheng Shi
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

10.  Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells.

Authors:  Marcelo N Tanaka; Bruno L Diaz; Wanderley de Souza; Jose A Morgado-Diaz
Journal:  BMC Cell Biol       Date:  2008-12-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.